Wow .... I can't imagine that NVS would consider acquiring MNTA until after the FDA makes a formal decision on the mL ANDA. It might be a great (and mutually beneficial) acquisition in a multi-generic mL approval scenario.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.